Detalhe da pesquisa
1.
Incidence of skin hyperpigmentation in Black patients receiving treatment with immunomodulatory drugs.
Blood
; 137(21): 2987-2989, 2021 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33728443
2.
Underrepresentation of Black participants and adverse events in clinical trials of lenalidomide for myeloma.
Crit Rev Oncol Hematol
; 172: 103644, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35227897
3.
Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics.
Nat Commun
; 13(1): 5789, 2022 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36184661
4.
Transitioning From Thrombopoietin Agonists to the Novel SYK Inhibitor Fostamatinib: A Multicenter, Real-World Case Series.
J Adv Pract Oncol
; 12(5): 508-517, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34430061
5.
Standard 30-minute Monitoring Time and Less Intensive Pre-medications is Safe in Patients Treated With Subcutaneous Daratumumab for Multiple Myeloma and Light Chain Amyloidosis.
Clin Lymphoma Myeloma Leuk
; 22(8): 566-568, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35367193